These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 781835)
21. Metabolic acidosis improves airway conductance in patients with asthma. Brijker F; van den Elshout FJ; Bosch FH; Heijdra YF; Folgering HT J Asthma; 2009 Sep; 46(7):656-8. PubMed ID: 19728200 [TBL] [Abstract][Full Text] [Related]
22. Nocturnal asthma: effect of a once per evening dose of sustained release theophylline. Neuenkirchen H; Wilkens JH; Oellerich M; Sybrecht GW Eur J Respir Dis; 1985 Mar; 66(3):196-204. PubMed ID: 3884358 [TBL] [Abstract][Full Text] [Related]
23. Italian multicenter study on the treatment of chronic obstructive lung disease with bromhexine. A double-blind placebo-controlled trial. Valenti S; Marenco G Respiration; 1989; 56(1-2):11-5. PubMed ID: 2690235 [TBL] [Abstract][Full Text] [Related]
25. Bromhexine for otitis media with effusion. Roydhouse N N Z Med J; 1981 Nov; 94(696):373-5. PubMed ID: 7033848 [TBL] [Abstract][Full Text] [Related]
26. Functional and clinical evaluation of feprazonebromhexine association in bronchopulmonary diseases. Del Bono N; Quartieri F; Renda B; Sconosciuto F; Vibelli C Panminerva Med; 1978; 20(2):117-22. PubMed ID: 360150 [No Abstract] [Full Text] [Related]
27. Expectorant action of bromhexine in chronic obstructive bronchitis. Hamilton WF; Palmer KN; Gent M Br Med J; 1970 Aug; 3(5717):260-1. PubMed ID: 4915361 [TBL] [Abstract][Full Text] [Related]
28. [Rifampicin concentrations in the sputum before and after administration of bromohexine (author's transl)]. Dold U; Petersen KF Prax Klin Pneumol; 1978 Aug; 32(8):543-50. PubMed ID: 683946 [No Abstract] [Full Text] [Related]
29. Role of bromhexine in exacerbations of bronchiectasis. Double-blind randomized multicenter study versus placebo. Olivieri D; Ciaccia A; Marangio E; Marsico S; Todisco T; Del Vita M Respiration; 1991; 58(3-4):117-21. PubMed ID: 1745841 [TBL] [Abstract][Full Text] [Related]
30. [Use of the mucoregulator ascoril for respiratory diseases]. Shmeleva NM Ter Arkh; 2012; 84(10):86-90. PubMed ID: 23227508 [TBL] [Abstract][Full Text] [Related]
31. A between-patient, double-blind comparison of S-carboxymethylcysteine and bromhexine in chronic obstructive bronchitis. Aylward M Curr Med Res Opin; 1973; 1(4):219-27. PubMed ID: 4589629 [No Abstract] [Full Text] [Related]
32. A controlled trial of bromhexine ('Bisolvon') in out-patients with chronic bronchitis. Lal S; Bhalla KK Curr Med Res Opin; 1975; 3(2):63-7. PubMed ID: 1095307 [TBL] [Abstract][Full Text] [Related]
33. Effect of bromhexine on ventilatory capacity in patients with a variety of chest diseases. Gent M; Knowlson PA; Rime FJ Lancet; 1969 Nov; 2(7630):1094-6. PubMed ID: 4186992 [No Abstract] [Full Text] [Related]
35. [Experimental study of the effects of bromelain on the sputum consistency in rabbits]. Suzuki K; Niho T; Yamada H; Yamaguchi K; Ohnishi H Nihon Yakurigaku Zasshi; 1983 Mar; 81(3):211-6. PubMed ID: 6862320 [TBL] [Abstract][Full Text] [Related]
37. Double-blind clinical trial of bromhexine as a mucolytic drug in chronic bronchitis. Langlands JH Lancet; 1970 Feb; 1(7644):448-50. PubMed ID: 4189753 [No Abstract] [Full Text] [Related]
38. The mucolytic agent bromhexine (bisolvon) in chronic lung disease. A double-blind crossover trial. Cobbin DM; Elliott FM; Rebuck AS Aust N Z J Med; 1971 May; 1(2):137-40. PubMed ID: 4935896 [No Abstract] [Full Text] [Related]
39. The expectorant effect of glyceryl guaiacolate in patients with chronic bronchitis. A controlled in vitro and in vivo study. Hirsch SR; Viernes PF; Kory RC Chest; 1973 Jan; 63(1):9-14. PubMed ID: 4567445 [No Abstract] [Full Text] [Related]